Full-Time

Étudiant d’été

Marketing, Oncology

Posted on 2/14/2025

Pfizer

Pfizer

10,001+ employees

Develops and manufactures vaccines and medicines

Compensation Overview

$19 - $28Hourly

Entry

No H1B Sponsorship

Pointe-Claire, QC, Canada

Employees are required to work on-site 2.5 to 3 days per week.

Category
General Marketing
Growth Marketing
Growth & Marketing
Required Skills
Marketing
Excel/Numbers/Sheets
Requirements
  • Experience working with excel
  • Organized detail-oriented individual
  • Bilingualism (French and English) - must be able to communicate well in English, as his or her duties require interaction with stakeholders and colleagues outside Quebec and Canada.
  • Enrolled full time in the upcoming academic semester and submit proof of registration upon hire (Fall 2025)
  • Legally authorized to work in Canada
Responsibilities
  • Aid in the organization of internal and external events and meetings
  • Budget review and monitoring
  • Support advertising planning & coordination
  • Assist with sales tool approval, management & alignment to new Global Pfizer branding
  • Support ad hoc projects for the Oncology Marketing Team
  • Support the Patient Support Program processes and team in various assignments

Pfizer is a biopharmaceutical company that focuses on creating and manufacturing healthcare products, including medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then commercialized and sold to various clients such as governments, healthcare providers, and patients. Pfizer's products include vaccines, oncology treatments, and specialized medicines. A notable achievement is its partnership with BioNTech to develop a vaccine for COVID-19, which has been widely distributed. Pfizer aims to improve public health by providing access to vaccines, especially in underserved areas, and continues to grow its product offerings with new approvals and treatments.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1849

Simplify Jobs

Simplify's Take

What believers are saying

  • Activist investor Starboard Value's $1B stake may drive strategic changes and increase value.
  • Pfizer's investment in Enara Bio strengthens its position in the immunotherapy market.
  • Backing Promise Bio aligns with Pfizer's strategy to enhance its precision medicine portfolio.

What critics are saying

  • Emerging biotech companies like Trimtech and Normunity could impact Pfizer's market share.
  • Slowdown in COVID-19 vaccine demand poses potential revenue challenges for Pfizer.
  • Activist investor involvement may pressure Pfizer to alter business strategies.

What makes Pfizer unique

  • Pfizer's partnership with BioNTech led to a highly effective COVID-19 vaccine.
  • Pfizer invests in AI disease models, enhancing R&D capabilities and drug discovery.
  • Pfizer's focus on precision medicine diversifies its therapeutic areas and strengthens its portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

Relocation Assistance

Company News

Finsmes
Mar 5th, 2025
Trimtech Therapeutics Raises $31M in Seed Funding

Trimtech Therapeutics, a Cambridge, UK-based biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases, raised $31M in Seed funding

Business Wire
Jan 16th, 2025
Normunity Closes $75 Million Series B Financing to Advance Lead Drug Program Into the Clinic and Broaden Pipeline of Novel Anti-Cancer Therapies Targeting Untapped Drug Mechanisms

Normunity, a biotechnology company creating novel anti-cancer therapies, today announced that it has closed a Series B financing for $75 million. The

TechCrunch
Oct 23rd, 2024
Promise Bio exits stealth backed by Pfizer and AstraZeneca | TechCrunch

The company has made it easier to test for different protein modifications which are critical to the treatment of autoimmune diseases.

The Wall Street Journal
Oct 7th, 2024
Exclusive | Activist Starboard Value Takes $1 Billion Stake in Pfizer

The drugmaker’s shares have slumped as demand for Covid-19 vaccines and treatments had slowed.

Benzinga
Oct 3rd, 2024
Enara Bio raises $32.5 million Series B financing to advance first-in-class pipeline of TCR-based immunotherapies targeting novel Dark Antigens®

New investors Pfizer Ventures and M Ventures co-led the financing, with participation from all existing investors including RA Capital, Samsara BioCapital and SV Health InvestorsEnara Bio's EDAPT® platform is

INACTIVE